Chester County News and Community Website
Prediabetes, a reversible condition affecting more than a third of adults in the United States, is the focus of new public service announcements (PSAs) launched by the Centers for Disease …
CDC and Ad Council Launch New PSAs to Raise Prediabetes Awareness Read More
MALVERN, PA — LifeScan announced that results from the study of real-world evidence Sustained Improvements in Readings In-Range Using an Advanced Bluetooth® Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World …
Real-World Study Finds App & Meter Combo Can Significantly Improve Diabetes Outcomes Read More
U.S. Senator Bob Casey (D-PA) released a statement on Eli Lilly’s announcement this week to automatically cap out-of-pocket insulin costs at $35 a month. In August 2022, Democrats in Congress …
Senator Casey Delivers Good News for Diabetes Patients Read More MALVERN, PA — LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology (JDST) has published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World …
Study: Significant Improvements in Glycemic Control Using a Smart Blood Glucose Meter and Mobile App Read More
The U. S. Department of Health and Human Services, through the Indian Health Service, recently announced that it is investing $139 million in funding for the Fiscal Year 2023 Special …
HHS Awards $139 Million for Special Diabetes Program for Indians Read More The U.S. Department of Health and Human Services (HHS) recently issued a new report showing the major savings coming to people with Medicare thanks to the $35 cap on a …
New HHS Report Finds Major Savings for Americans Who Use Insulin Read More Intermittent fasting may help Type 2 diabetes patients discontinue medication, according to a small study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. After an intermittent fasting …
Study Shows That Intermittent Fasting May Help Type 2 Diabetes Patients Discontinue Medication Read More
The U.S. Food and Drug Administration recently approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type 1 diabetes in adults and pediatric patients 8 years and older …
FDA Approves First Drug That Can Delay Onset of Type 1 Diabetes Read More MALVERN, PA — LifeScan announced recruitment for a new study that will evaluate the clinical and economic value of using the digital health subscriptions offered through OneTouch® Solutions for people with type 2 …
New Study Will Examine Benefits for People with Type 2 Diabetes When Personalized Wellness Technologies Are Paired With Smart Blood Glucose Ecosystem Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration says that it recently approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an …
FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes Read More